ECOMB (ECOMB) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jun, 2025Executive summary
Revenue increased to 18,800 TSEK for 2024, up from 5,125 TSEK year-over-year, driven by the large Enköping project, but project overruns led to a record net loss of -9,159 TSEK compared to -2,388 TSEK last year.
The Enköping Ecotube project was significantly over budget due to a key subcontractor's withdrawal, resulting in higher costs and delayed timelines.
Strategic focus expanded to PFAS reduction via subsidiary Ocean Recycle, with a new patent granted and a partnership initiated with Clean Nature AB.
Share consolidation (150:1) and a switch from Spotlight to NGM Nordic SME were completed to reduce costs and improve capital structure.
Financial highlights
Net loss after financial items was -9,159 TSEK (2023: -2,388 TSEK); EBITDA and EBIT both negative.
Cash and cash equivalents at year-end were -3,488 TSEK (2023: -840 TSEK); cash flow for the year was -2,648 TSEK.
Equity ratio at 11.13% with equity of 1,522 TSEK; accumulated tax loss carryforward of 56,781 TSEK.
No dividend proposed for 2024.
Share capital increased via a rights issue, raising 5.5 MSEK net and increasing shares from 38.4M to 90M before consolidation.
Outlook and guidance
Management expresses strong confidence in future prospects for both core Ecotube and PFAS solutions, despite current financial challenges.
Additional capital may be required if sales cycles remain long; new emission in Ocean Recycle planned for 2025.
Concrete results from new business areas expected in 2025.
Latest events from ECOMB
- Financial turnaround driven by new capital, project wins, and strategic focus on CCS and PFAS.ECOMB
Q4 202527 Feb 2026 - Sales fell, losses narrowed, and a major rights issue will fund new emission and water projects.ECOMB
Q3 202528 Nov 2025 - Severe cash strain and losses persist, but future prospects hinge on new contracts and PFAS focus.ECOMB
Q2 202529 Aug 2025 - Revenue surged on project delivery, but losses widened and liquidity remains tight.ECOMB
Q3 202413 Jun 2025 - Sales up, losses incurred, capital raised, and new PFAS tech validated for future growth.ECOMB
Q2 202413 Jun 2025 - Q1 2025 saw steep losses and cash strain, but key projects in NOx and PFAS advanced.ECOMB
Q1 20256 Jun 2025